-
1
-
-
0037049977
-
Cardiac excitation-contraction coupling
-
Bers DM: Cardiac excitation-contraction coupling. Nature 2002; 415: 198-205.
-
(2002)
Nature
, vol.415
, pp. 198-205
-
-
Bers, D.M.1
-
2
-
-
0034509410
-
Phospholamban and cardiac contractile function
-
Brittsan AG, Kranias EG: Phospholamban and cardiac contractile function. J Mol Cell Cardiol 2000, 32: 2131-2139.
-
(2000)
J Mol Cell Cardiol
, vol.32
, pp. 2131-2139
-
-
Brittsan, A.G.1
Kranias, E.G.2
-
3
-
-
0025773177
-
Abnormal intracellular modulation of calcium as a major cause of cardiac contractile dysfunction
-
Morgan JP: Abnormal intracellular modulation of calcium as a major cause of cardiac contractile dysfunction. N Engl J Med 1991; 325: 625-632.
-
(1991)
N Engl J Med
, vol.325
, pp. 625-632
-
-
Morgan, J.P.1
-
4
-
-
0001078987
-
Alterations of calcium-regulatory proteins in heart failure
-
Hasenfuss G: Alterations of calcium-regulatory proteins in heart failure. Cardiovasc Res 1998; 37: 279-289.
-
(1998)
Cardiovasc Res
, vol.37
, pp. 279-289
-
-
Hasenfuss, G.1
-
5
-
-
0033804245
-
Abnormalities of calcium cycling in the hypertrophied and failing heart
-
Houser SR, Piacentino V, 3rd, et al: Abnormalities of calcium cycling in the hypertrophied and failing heart. J Mol Cell Cardiol 2000; 32: 1595-1607.
-
(2000)
J Mol Cell Cardiol
, vol.32
, pp. 1595-1607
-
-
Houser, S.R.1
Piacentino 3rd, V.2
-
6
-
-
0028987859
-
2+]i handling in human ventricular myocytes from patients with terminal heart failure
-
2+]i handling in human ventricular myocytes from patients with terminal heart failure. Am Heart J 1995; 129: 684-689.
-
(1995)
Am Heart J
, vol.129
, pp. 684-689
-
-
Beuckelmann, D.J.1
Nabauer, M.2
Kruger, C.3
-
7
-
-
0027423351
-
The epidemiology of heart failure: The Framingham Study
-
Ho KK, Pinsky JL, Kannel WB, et al: The epidemiology of heart failure: the Framingham Study. J Am Coll Cardiol 1993, 22: 6A-13A
-
(1993)
J Am Coll Cardiol
, vol.22
-
-
Ho, K.K.1
Pinsky, J.L.2
Kannel, W.B.3
-
8
-
-
35348955639
-
-
American Heart Association: In: http://www.americanheart. org/presenter.jhtml?identifier=1486.
-
http
-
-
-
10
-
-
0029029280
-
Fractional SR Ca release is regulated by trigger Ca and SR Ca content in cardiac myocytes
-
Bassani JW, Yuan W, Bers DM: Fractional SR Ca release is regulated by trigger Ca and SR Ca content in cardiac myocytes. Am J Physiol 1995, 268: C1313-1319.
-
(1995)
Am J Physiol
, vol.268
-
-
Bassani, J.W.1
Yuan, W.2
Bers, D.M.3
-
11
-
-
0345413285
-
Model of intracellular calcium cycling in ventricular myocytes
-
Shiferaw Y, Watanabe MA, Garfinkel A, et al: Model of intracellular calcium cycling in ventricular myocytes. Biophys J 2003; 85: 3666-3686.
-
(2003)
Biophys J
, vol.85
, pp. 3666-3686
-
-
Shiferaw, Y.1
Watanabe, M.A.2
Garfinkel, A.3
-
13
-
-
0034036663
-
Potentiation of fractional sarcoplasmic reticulum calcium release by total and free intra-sarcoplasmic reticulum calcium concentration
-
Shannon TR, Ginsburg KS, Bers DM: Potentiation of fractional sarcoplasmic reticulum calcium release by total and free intra-sarcoplasmic reticulum calcium concentration. Biophys J 2000; 78: 334-343.
-
(2000)
Biophys J
, vol.78
, pp. 334-343
-
-
Shannon, T.R.1
Ginsburg, K.S.2
Bers, D.M.3
-
16
-
-
0037465735
-
A guide for the perplexed: Towards an understanding of the molecular basis of heart failure
-
Marks AR: A guide for the perplexed: towards an understanding of the molecular basis of heart failure. Circulation 2003; 107: 1456-1459.
-
(2003)
Circulation
, vol.107
, pp. 1456-1459
-
-
Marks, A.R.1
-
17
-
-
0030805905
-
2+ ATPase gene in the heart of transgenic mice accelerates calcium transients and cardiac relaxation
-
2+ ATPase gene in the heart of transgenic mice accelerates calcium transients and cardiac relaxation. J Clin Invest 1997; 100: 380-389.
-
(1997)
J Clin Invest
, vol.100
, pp. 380-389
-
-
He, H.1
Giordano, F.J.2
Hilal-Dandan, R.3
-
18
-
-
0032576586
-
2+-ATPase increases cardiac contractility in transgenic mouse hearts
-
2+-ATPase increases cardiac contractility in transgenic mouse hearts. Circ Res 1998; 83: 1205-1214.
-
(1998)
Circ Res
, vol.83
, pp. 1205-1214
-
-
Baker, D.L.1
Hashimoto, K.2
Grupp, I.L.3
-
19
-
-
0037264995
-
2+ affinity mutant of SERCA2a attenuates in vivo pressure overload cardiac hypertrophy
-
2+ affinity mutant of SERCA2a attenuates in vivo pressure overload cardiac hypertrophy. Faseb J 2003; 17: 61-63.
-
(2003)
Faseb J
, vol.17
, pp. 61-63
-
-
Nakayama, H.1
Otsu, K.2
Yamaguchi, O.3
-
21
-
-
0034537410
-
2+ homeostasis and cardiomyocyte function
-
2+ homeostasis and cardiomyocyte function. J Biol Chem 2000; 275: 38073-38080.
-
(2000)
J Biol Chem
, vol.275
, pp. 38073-38080
-
-
Ji, Y.1
Lalli, M.J.2
Babu, G.J.3
-
22
-
-
0030767865
-
Adenoviral gene transfer of phospholamban in isolated rat cardiomyocytes. Rescue effects by concomitant gene transfer of sarcoplasmic reticulum Ca(2+)-ATPase
-
Hajjar RJ, Schmidt U, Kang JX, et al: Adenoviral gene transfer of phospholamban in isolated rat cardiomyocytes. Rescue effects by concomitant gene transfer of sarcoplasmic reticulum Ca(2+)-ATPase. Circ Res 1997; 81: 145-153.
-
(1997)
Circ Res
, vol.81
, pp. 145-153
-
-
Hajjar, R.J.1
Schmidt, U.2
Kang, J.X.3
-
23
-
-
0035793918
-
Adenoviral-mediated serca gene transfer into cardiac myocytes: How much is too much?
-
Periasamy M: Adenoviral-mediated serca gene transfer into cardiac myocytes: how much is too much? Circ Res 2001; 88: 373-375.
-
(2001)
Circ Res
, vol.88
, pp. 373-375
-
-
Periasamy, M.1
-
24
-
-
0027932798
-
Targeted ablation of the phospholamban gene is associated with markedly enhanced myocardial contractility and loss of beta-agonist stimulation
-
Luo W, Grupp IL, Harrer J, et al: Targeted ablation of the phospholamban gene is associated with markedly enhanced myocardial contractility and loss of beta-agonist stimulation. Circ Res 1994; 75: 401-409.
-
(1994)
Circ Res
, vol.75
, pp. 401-409
-
-
Luo, W.1
Grupp, I.L.2
Harrer, J.3
-
25
-
-
9244255361
-
Phospholamban gene dosage effects in the mammalian heart
-
Luo W, Wolska BM, Grupp IL, et al: Phospholamban gene dosage effects in the mammalian heart. Circ Res 1996; 78: 839-847.
-
(1996)
Circ Res
, vol.78
, pp. 839-847
-
-
Luo, W.1
Wolska, B.M.2
Grupp, I.L.3
-
26
-
-
0030032378
-
Cardiac-specific overexpression of phospholamban alters calcium kinetics and resultant cardiomyocyte mechanics in transgenic mice
-
Kadambi VJ, Ponniah S, Harrer JM, et al: Cardiac-specific overexpression of phospholamban alters calcium kinetics and resultant cardiomyocyte mechanics in transgenic mice. J Clin Invest 1996; 97: 533-539.
-
(1996)
J Clin Invest
, vol.97
, pp. 533-539
-
-
Kadambi, V.J.1
Ponniah, S.2
Harrer, J.M.3
-
27
-
-
0030905733
-
2+ pump and phospholamban in Spodoptera frugiperda (Sf21) cells reveals new insights on ATPase regulation
-
2+ pump and phospholamban in Spodoptera frugiperda (Sf21) cells reveals new insights on ATPase regulation. J Biol Chem 1997; 272: 15872-15880.
-
(1997)
J Biol Chem
, vol.272
, pp. 15872-15880
-
-
Autry, J.M.1
Jones, L.R.2
-
28
-
-
0035968264
-
Superinhibition of sarcoplasmic reticulum function by phospholamban induces cardiac contractile failure
-
Haghighi K, Schmidt AG, Hoit BD, et al: Superinhibition of sarcoplasmic reticulum function by phospholamban induces cardiac contractile failure. J Biol Chem 2001; 276: 24145-24152.
-
(2001)
J Biol Chem
, vol.276
, pp. 24145-24152
-
-
Haghighi, K.1
Schmidt, A.G.2
Hoit, B.D.3
-
29
-
-
0034685881
-
The transgenic expression of highly inhibitory monomeric forms of phospholamban in mouse heart impairs cardiac contractility
-
Zvaritch E, Backx PH, Jirik F, et al: The transgenic expression of highly inhibitory monomeric forms of phospholamban in mouse heart impairs cardiac contractility. J Biol Chem 2000; 275: 14985-14991.
-
(2000)
J Biol Chem
, vol.275
, pp. 14985-14991
-
-
Zvaritch, E.1
Backx, P.H.2
Jirik, F.3
-
30
-
-
0034616217
-
Cardiac-specific overexpression of a superinhibitory pentameric phospholamban mutant enhances inhibition of cardiac function in vivo
-
Zhai J, Schmidt AG, Hoit BD, et al: Cardiac-specific overexpression of a superinhibitory pentameric phospholamban mutant enhances inhibition of cardiac function in vivo. J Biol Chem 2000; 275: 10538-10544.
-
(2000)
J Biol Chem
, vol.275
, pp. 10538-10544
-
-
Zhai, J.1
Schmidt, A.G.2
Hoit, B.D.3
-
32
-
-
0036702666
-
Calcium cycling in congestive heart failure
-
Hasenfuss G, Pieske B: Calcium cycling in congestive heart failure. J Mol Cell Cardiol 2002; 34: 951-969.
-
(2002)
J Mol Cell Cardiol
, vol.34
, pp. 951-969
-
-
Hasenfuss, G.1
Pieske, B.2
-
33
-
-
0034950082
-
Beta-adrenergic receptors and calcium cycling proteins in non-failing, hypertrophied and failing human hearts: Transition from hypertrophy to failure
-
DiPaola NR, Sweet WE, Stull LB, Francis GS, Schomisch Moravec C: Beta-adrenergic receptors and calcium cycling proteins in non-failing, hypertrophied and failing human hearts: transition from hypertrophy to failure. J Mol Cell Cardiol 2001; 33: 1283-1295.
-
(2001)
J Mol Cell Cardiol
, vol.33
, pp. 1283-1295
-
-
DiPaola, N.R.1
Sweet, W.E.2
Stull, L.B.3
Francis, G.S.4
Schomisch Moravec, C.5
-
34
-
-
0028101383
-
Relation between myocardial function and expression of sarcoplasmic reticulum Ca(2+)-ATPase in failing and nonfailing human myocardium
-
Hasenfuss G, Reinecke H, Studer R, et al: Relation between myocardial function and expression of sarcoplasmic reticulum Ca(2+)-ATPase in failing and nonfailing human myocardium. Circ Res 1994; 75: 434-442.
-
(1994)
Circ Res
, vol.75
, pp. 434-442
-
-
Hasenfuss, G.1
Reinecke, H.2
Studer, R.3
-
35
-
-
0029092577
-
Alterations of sarcoplasmic reticulum proteins in failing human dilated cardiomyopathy
-
Meyer M, Schillinger W, Pieske B, et al: Alterations of sarcoplasmic reticulum proteins in failing human dilated cardiomyopathy. Circulation 1995; 92: 778-784.
-
(1995)
Circulation
, vol.92
, pp. 778-784
-
-
Meyer, M.1
Schillinger, W.2
Pieske, B.3
-
37
-
-
0033105384
-
Reduced Ca(2+)-sensitivity of SERCA 2a in failing human myocardium due to reduced serin-16 phospholamban phosphorylation
-
Schwinger RH, Munch G, Bolck B, et al: Reduced Ca(2+)-sensitivity of SERCA 2a in failing human myocardium due to reduced serin-16 phospholamban phosphorylation. J Mol Cell Cardiol 1999; 31: 479-491.
-
(1999)
J Mol Cell Cardiol
, vol.31
, pp. 479-491
-
-
Schwinger, R.H.1
Munch, G.2
Bolck, B.3
-
39
-
-
0028882650
-
2+ uptake and Ca(2+)-ATPase activity of cardiac sarcoplasmic reticulum from dilated cardiomyopathy patients compared with patients with nonfailing hearts
-
2+ uptake and Ca(2+)-ATPase activity of cardiac sarcoplasmic reticulum from dilated cardiomyopathy patients compared with patients with nonfailing hearts. Circulation 1995; 92: 3220-3228.
-
(1995)
Circulation
, vol.92
, pp. 3220-3228
-
-
Schwinger, R.H.1
Bohm, M.2
Schmidt, U.3
-
40
-
-
12944332074
-
Adenoviral gene transfer of SERCA2a improves left-ventricular function in aortic-banded rats in transition to heart failure
-
Miyamoto MI, del Monte F, Schmidt U, et al: Adenoviral gene transfer of SERCA2a improves left-ventricular function in aortic-banded rats in transition to heart failure. Proc Natl Acad Sci U S A 2000; 97: 793-798.
-
(2000)
Proc Natl Acad Sci U S A
, vol.97
, pp. 793-798
-
-
Miyamoto, M.I.1
del Monte, F.2
Schmidt, U.3
-
41
-
-
0035908945
-
Improvement in survival and cardiac metabolism after gene transfer of sarcoplasmic reticulum Ca(2+)-ATPase in a rat model of heart failure
-
del Monte F, Williams E, Lebeche D, et al: Improvement in survival and cardiac metabolism after gene transfer of sarcoplasmic reticulum Ca(2+)-ATPase in a rat model of heart failure. Circulation 2001; 104: 1424-1429.
-
(2001)
Circulation
, vol.104
, pp. 1424-1429
-
-
del Monte, F.1
Williams, E.2
Lebeche, D.3
-
42
-
-
0036227758
-
Overexpression of the sarcoplasmic reticulum Ca(2+)-ATPase improves myocardial contractility in diabetic cardiomyopathy
-
Trost SU, Belke DD, Bluhm WF, et al: Overexpression of the sarcoplasmic reticulum Ca(2+)-ATPase improves myocardial contractility in diabetic cardiomyopathy. Diabetes 2002; 51: 1166-1171.
-
(2002)
Diabetes
, vol.51
, pp. 1166-1171
-
-
Trost, S.U.1
Belke, D.D.2
Bluhm, W.F.3
-
43
-
-
1842732159
-
-
Del Monte F, Lebeche D, Guerrero JL, et al: Abrogation of ventricular arrhythmias in a model of ischemia and reperfusion by targeting myocardial calcium cycling. Proc Natl Acad Sci U S A 2004.
-
Del Monte F, Lebeche D, Guerrero JL, et al: Abrogation of ventricular arrhythmias in a model of ischemia and reperfusion by targeting myocardial calcium cycling. Proc Natl Acad Sci U S A 2004.
-
-
-
-
44
-
-
0036341380
-
Chronic supression of heart-failure progression by a pseudophosphorylated mutant of phospholamban via in vivo cardiac rAAV gene delivery
-
Hoshijima M, Ikeda Y, Iwanaga Y, et al: Chronic supression of heart-failure progression by a pseudophosphorylated mutant of phospholamban via in vivo cardiac rAAV gene delivery. Nature Medicine 2002, 8: 864-871.
-
(2002)
Nature Medicine
, vol.8
, pp. 864-871
-
-
Hoshijima, M.1
Ikeda, Y.2
Iwanaga, Y.3
-
45
-
-
85047689989
-
Chronic phospholamban inhibition prevents progressive cardiac dysfunction and pathological remodeling after infarction in rats
-
Iwanaga Y, Hoshijima M, Gu Y, et al: Chronic phospholamban inhibition prevents progressive cardiac dysfunction and pathological remodeling after infarction in rats. J Clin Invest 2004; 113: 727-736.
-
(2004)
J Clin Invest
, vol.113
, pp. 727-736
-
-
Iwanaga, Y.1
Hoshijima, M.2
Gu, Y.3
-
46
-
-
0033615645
-
Chronic phospholamban- sarcoplasmic reticulum calcium ATPase interaction is the critical calcium cycling defect in dilated cardiomyopathy
-
Minamisawa S, Hoshijima M, Chu G, et al: Chronic phospholamban- sarcoplasmic reticulum calcium ATPase interaction is the critical calcium cycling defect in dilated cardiomyopathy. Cell 1999; 99: 313-322.
-
(1999)
Cell
, vol.99
, pp. 313-322
-
-
Minamisawa, S.1
Hoshijima, M.2
Chu, G.3
-
47
-
-
0035048223
-
Alterations in cardiac adrenergic signaling and calcium cycling differentially affect the progression of cardiomyopathy
-
Freeman K, Lerman I, Kranias EG, et al: Alterations in cardiac adrenergic signaling and calcium cycling differentially affect the progression of cardiomyopathy. J Clin Invest 2001; 107: 967-974.
-
(2001)
J Clin Invest
, vol.107
, pp. 967-974
-
-
Freeman, K.1
Lerman, I.2
Kranias, E.G.3
-
48
-
-
0035937762
-
Rescue of contractile parameters and myocyte hypertrophy in calsequestrin overexpressing myocardium by phospholamban ablation
-
Sato Y, Kiriazis H, Yatani A, et al: Rescue of contractile parameters and myocyte hypertrophy in calsequestrin overexpressing myocardium by phospholamban ablation. J Biol Chem 2001; 276: 9392-9399.
-
(2001)
J Biol Chem
, vol.276
, pp. 9392-9399
-
-
Sato, Y.1
Kiriazis, H.2
Yatani, A.3
-
49
-
-
1542409908
-
Altered calcium handling is critically involved in the cardiotoxic effects of chronic beta-adrenergic stimulation
-
Engelhardt S, Hein L, Dyachenkow V, et al: Altered calcium handling is critically involved in the cardiotoxic effects of chronic beta-adrenergic stimulation. Circulation 2004; 109: 1154-1160.
-
(2004)
Circulation
, vol.109
, pp. 1154-1160
-
-
Engelhardt, S.1
Hein, L.2
Dyachenkow, V.3
-
50
-
-
0033534053
-
Restoration of contractile function in isolated cardiomyocytes from failing human hearts by gene transfer of SERCA2a
-
del Monte F, Harding SE, Schmidt U, et al: Restoration of contractile function in isolated cardiomyocytes from failing human hearts by gene transfer of SERCA2a. Circulation 1999; 100: 2308-2311.
-
(1999)
Circulation
, vol.100
, pp. 2308-2311
-
-
del Monte, F.1
Harding, S.E.2
Schmidt, U.3
-
51
-
-
0037176978
-
Targeting phospholamban by gene transfer in human heart failure
-
del Monte F, Harding SE, Dec GW, et al: Targeting phospholamban by gene transfer in human heart failure. Circulation 2002; 105: 904-907.
-
(2002)
Circulation
, vol.105
, pp. 904-907
-
-
del Monte, F.1
Harding, S.E.2
Dec, G.W.3
-
52
-
-
0012300264
-
Re-evaluating sarcoplasmic reticulum function in heart failure
-
Delling U, Sussman MA, Molkentin JD: Re-evaluating sarcoplasmic reticulum function in heart failure. Nat Med 2000; 6: 942-943.
-
(2000)
Nat Med
, vol.6
, pp. 942-943
-
-
Delling, U.1
Sussman, M.A.2
Molkentin, J.D.3
-
53
-
-
0037362850
-
Rescue of cardiomyocyte dysfunction by phospholamban ablation does not prevent ventricular failure in genetic hypertrophy
-
Song Q, Schmidt AG, Hahn HS, et al: Rescue of cardiomyocyte dysfunction by phospholamban ablation does not prevent ventricular failure in genetic hypertrophy. J Clin Invest 2003; 111: 859-867.
-
(2003)
J Clin Invest
, vol.111
, pp. 859-867
-
-
Song, Q.1
Schmidt, A.G.2
Hahn, H.S.3
-
54
-
-
2442501143
-
Phospholamban gene ablation improves calcium transients but not cardiac function in a heart failure model
-
Janczewski AM, Zahid M, Lemster BH, et al: Phospholamban gene ablation improves calcium transients but not cardiac function in a heart failure model. Cardiovasc Res 2004; 62: 468-480.
-
(2004)
Cardiovasc Res
, vol.62
, pp. 468-480
-
-
Janczewski, A.M.1
Zahid, M.2
Lemster, B.H.3
-
55
-
-
0037470512
-
Dilated cardiomyopathy and heart failure caused by a mutation in phospholamban
-
Schmitt JP, Kamisago M, Asahi M, et al: Dilated cardiomyopathy and heart failure caused by a mutation in phospholamban. Science 2003; 299: 1410-1413.
-
(2003)
Science
, vol.299
, pp. 1410-1413
-
-
Schmitt, J.P.1
Kamisago, M.2
Asahi, M.3
-
56
-
-
85047687537
-
Human phospholamban null results in lethal dilated cardiomyopathy revealing a critical difference between mouse and human
-
Haghighi K, Kolokathis F, Pater L, et al: Human phospholamban null results in lethal dilated cardiomyopathy revealing a critical difference between mouse and human. J Clin Invest 2003; 111: 869-876.
-
(2003)
J Clin Invest
, vol.111
, pp. 869-876
-
-
Haghighi, K.1
Kolokathis, F.2
Pater, L.3
-
57
-
-
0344406208
-
Mutation of the phospholamban promoter associated with hypertrophic cardiomyopathy
-
Minamisawa S, Sato Y, Tatsuguchi Y, et al: Mutation of the phospholamban promoter associated with hypertrophic cardiomyopathy. Biochem Biophys Res Commun 2003; 304: 1-4.
-
(2003)
Biochem Biophys Res Commun
, vol.304
, pp. 1-4
-
-
Minamisawa, S.1
Sato, Y.2
Tatsuguchi, Y.3
-
58
-
-
0030770826
-
Complex formation between junctin, triadin, calsequestrin, and the ryanodine receptor. Proteins of the cardiac junctional sarcoplasmic reticulum membrane
-
Zhang L, Kelley J, Schmeisser G, et al: Complex formation between junctin, triadin, calsequestrin, and the ryanodine receptor. Proteins of the cardiac junctional sarcoplasmic reticulum membrane. J Biol Chem 1997; 272: 23389-23397.
-
(1997)
J Biol Chem
, vol.272
, pp. 23389-23397
-
-
Zhang, L.1
Kelley, J.2
Schmeisser, G.3
-
59
-
-
1942423621
-
The role of calsequestrin, triadin, and junctin in conferring cardiac ryanodine receptor responsiveness to luminal calcium
-
Gyorke I, Hester N, Jones LR, et al: The role of calsequestrin, triadin, and junctin in conferring cardiac ryanodine receptor responsiveness to luminal calcium. Biophys J 2004; 86: 2121-2128.
-
(2004)
Biophys J
, vol.86
, pp. 2121-2128
-
-
Gyorke, I.1
Hester, N.2
Jones, L.R.3
-
60
-
-
0033534056
-
Molecular inotropy: A future approach to the treatment of heart failure?
-
Barry WH: Molecular inotropy: a future approach to the treatment of heart failure? Circulation 1999; 100: 2303-2304.
-
(1999)
Circulation
, vol.100
, pp. 2303-2304
-
-
Barry, W.H.1
-
61
-
-
0036274039
-
Regulation of ryanodine receptors via macromolecular complexes: A novel role for leucine/ isoleucine zippers
-
Marks AR, Marx SO, Reiken S: Regulation of ryanodine receptors via macromolecular complexes: a novel role for leucine/ isoleucine zippers. Trends Cardiovasc Med 2002; 12: 166-170.
-
(2002)
Trends Cardiovasc Med
, vol.12
, pp. 166-170
-
-
Marks, A.R.1
Marx, S.O.2
Reiken, S.3
-
62
-
-
3242692393
-
Macromolecular complexes regulating cardiac ryanodine receptor function
-
Bers DM: Macromolecular complexes regulating cardiac ryanodine receptor function. J Mol Cell Cardiol 2004; 37: 417-429.
-
(2004)
J Mol Cell Cardiol
, vol.37
, pp. 417-429
-
-
Bers, D.M.1
-
63
-
-
0032526717
-
Embryonic lethality and abnormal cardiac myocytes in mice lacking ryanodine receptor type 2
-
Takeshima H, Komazaki S, Hirose K, et al: Embryonic lethality and abnormal cardiac myocytes in mice lacking ryanodine receptor type 2. Embo J 1998; 17: 3309-3316.
-
(1998)
Embo J
, vol.17
, pp. 3309-3316
-
-
Takeshima, H.1
Komazaki, S.2
Hirose, K.3
-
64
-
-
0035827726
-
Coupled gating between cardiac calcium release channels (ryanodine receptors)
-
Marx SO, Gaburjakova J, Gaburjakova M, et al: Coupled gating between cardiac calcium release channels (ryanodine receptors). Circ Res 2001; 88: 1151-1158.
-
(2001)
Circ Res
, vol.88
, pp. 1151-1158
-
-
Marx, S.O.1
Gaburjakova, J.2
Gaburjakova, M.3
-
65
-
-
0037708928
-
FKBP12.6 deficiency and defective calcium release channel (ryanodine receptor) function linked to exercise-induced sudden cardiac death
-
Wehrens XH, Lehnart SE, Huang F, et al: FKBP12.6 deficiency and defective calcium release channel (ryanodine receptor) function linked to exercise-induced sudden cardiac death. Cell 2003; 113: 829-840.
-
(2003)
Cell
, vol.113
, pp. 829-840
-
-
Wehrens, X.H.1
Lehnart, S.E.2
Huang, F.3
-
66
-
-
0037149508
-
Oestrogen protects FKBP12.6 null mice from cardiac hypertrophy
-
Xin HB, Senbonmatsu T, Cheng DS, et al: Oestrogen protects FKBP12.6 null mice from cardiac hypertrophy. Nature 2002; 416: 334-338.
-
(2002)
Nature
, vol.416
, pp. 334-338
-
-
Xin, H.B.1
Senbonmatsu, T.2
Cheng, D.S.3
-
67
-
-
0032576689
-
Cardiac defects and altered ryanodine receptor function in mice lacking FKBP12
-
Shou W, Aghdasi B, Armstrong DL, et al: Cardiac defects and altered ryanodine receptor function in mice lacking FKBP12. Nature 1998; 391: 489-492.
-
(1998)
Nature
, vol.391
, pp. 489-492
-
-
Shou, W.1
Aghdasi, B.2
Armstrong, D.L.3
-
68
-
-
0028809084
-
Differential regulation of two types of intracellular calcium release channels during end-stage heart failure
-
Go LO, Moschella MC, Watras J, et al: Differential regulation of two types of intracellular calcium release channels during end-stage heart failure. J Clin Invest 1995; 95: 888-894.
-
(1995)
J Clin Invest
, vol.95
, pp. 888-894
-
-
Go, L.O.1
Moschella, M.C.2
Watras, J.3
-
69
-
-
0029620947
-
The ryanodine binding sarcoplasmic reticulum calcium release channel in nonfailing and in failing human myocardium
-
Schumacher C, Konigs B, Sigmund M, et al: The ryanodine binding sarcoplasmic reticulum calcium release channel in nonfailing and in failing human myocardium. Naunyn Schmiedebergs Arch Pharmacol 1995; 353: 80-85.
-
(1995)
Naunyn Schmiedebergs Arch Pharmacol
, vol.353
, pp. 80-85
-
-
Schumacher, C.1
Konigs, B.2
Sigmund, M.3
-
70
-
-
0037195427
-
2+ release, but normal ryanodine receptors, in canine and human heart failure
-
2+ release, but normal ryanodine receptors, in canine and human heart failure. Circ Res 2002; 91: 1015-1022.
-
(2002)
Circ Res
, vol.91
, pp. 1015-1022
-
-
Jiang, M.T.1
Lokuta, A.J.2
Farrell, E.F.3
-
71
-
-
0031127992
-
Cardiac calcium release channel (ryanodine receptor) in control and cardiomyopathic human hearts: MRNA and protein contents are differentially regulated
-
Sainte Beuve C, Allen PD, Dambrin G, et al: Cardiac calcium release channel (ryanodine receptor) in control and cardiomyopathic human hearts: mRNA and protein contents are differentially regulated. J Mol Cell Cardiol 1997; 29: 1237-1246.
-
(1997)
J Mol Cell Cardiol
, vol.29
, pp. 1237-1246
-
-
Sainte Beuve, C.1
Allen, P.D.2
Dambrin, G.3
-
72
-
-
0024437435
-
Single channel recordings from human cardiac sarcoplasmic reticulum
-
Holmberg SR, Williams AJ: Single channel recordings from human cardiac sarcoplasmic reticulum. Circ Res 1989; 65: 1445-1449.
-
(1989)
Circ Res
, vol.65
, pp. 1445-1449
-
-
Holmberg, S.R.1
Williams, A.J.2
-
73
-
-
0034640113
-
PKA phosphorylation dissociates FKBP12.6 from the calcium release channel (ryanodine receptor): Defective regulation in failing hearts
-
Marx SO, Reiken S, Hisamatsu Y, et al: PKA phosphorylation dissociates FKBP12.6 from the calcium release channel (ryanodine receptor): defective regulation in failing hearts. Cell 2000; 101: 365-376.
-
(2000)
Cell
, vol.101
, pp. 365-376
-
-
Marx, S.O.1
Reiken, S.2
Hisamatsu, Y.3
-
74
-
-
0037414827
-
Protein kinase A phosphorylation of the cardiac calcium release channel (ryanodine receptor) in normal and failing hearts. Role of phosphatases and response to isoproterenol
-
Reiken S, Gaburjakova M, Guatimosim S, et al: Protein kinase A phosphorylation of the cardiac calcium release channel (ryanodine receptor) in normal and failing hearts. Role of phosphatases and response to isoproterenol. J Biol Chem 2003; 278: 444-453.
-
(2003)
J Biol Chem
, vol.278
, pp. 444-453
-
-
Reiken, S.1
Gaburjakova, M.2
Guatimosim, S.3
-
75
-
-
0034711171
-
Altered stoichiometry of FKBP12.6 versus ryanodine receptor as a cause of abnormal Ca(2+) leak through ryanodine receptor in heart failure
-
Yano M, Ono K, Ohkusa T, et al: Altered stoichiometry of FKBP12.6 versus ryanodine receptor as a cause of abnormal Ca(2+) leak through ryanodine receptor in heart failure. Circulation 2000; 102: 2131-2136.
-
(2000)
Circulation
, vol.102
, pp. 2131-2136
-
-
Yano, M.1
Ono, K.2
Ohkusa, T.3
-
76
-
-
0033770278
-
Altered interaction of FKBP 12.6 with ryanodine receptor as a cause of abnormal Ca(2+) release in heart failure
-
Ono K, Yano M, Ohkusa T, et al: Altered interaction of FKBP 12.6 with ryanodine receptor as a cause of abnormal Ca(2+) release in heart failure. Cardiovasc Res 2000; 48: 323-331.
-
(2000)
Cardiovasc Res
, vol.48
, pp. 323-331
-
-
Ono, K.1
Yano, M.2
Ohkusa, T.3
-
77
-
-
0037469180
-
FKBP12.6-mediated stabilization of calcium-release channel (ryanodine receptor) as a novel therapeutic strategy against heart failure
-
Yano M, Kobayashi S, Kohno M, et al: FKBP12.6-mediated stabilization of calcium-release channel (ryanodine receptor) as a novel therapeutic strategy against heart failure. Circulation 2003; 107: 477-484.
-
(2003)
Circulation
, vol.107
, pp. 477-484
-
-
Yano, M.1
Kobayashi, S.2
Kohno, M.3
-
78
-
-
1842482414
-
Protection from cardiac arrhythmia through ryanodine receptor-stabilizing protein calstabin2
-
Wehrens XH, Lehnart SE, Reiken SR, et al: Protection from cardiac arrhythmia through ryanodine receptor-stabilizing protein calstabin2. Science 2004; 304: 292-296.
-
(2004)
Science
, vol.304
, pp. 292-296
-
-
Wehrens, X.H.1
Lehnart, S.E.2
Reiken, S.R.3
-
79
-
-
0035793341
-
Overexpression of FK506-binding protein FKBP12.6 in cardiomyocytes reduces ryanodine receptor-mediated Ca(2+) leak from the sarcoplasmic reticulum and increases contractility
-
Prestle J, Janssen PM, Janssen AP, et al: Overexpression of FK506-binding protein FKBP12.6 in cardiomyocytes reduces ryanodine receptor-mediated Ca(2+) leak from the sarcoplasmic reticulum and increases contractility. Circ Res 2001; 88: 188-194.
-
(2001)
Circ Res
, vol.88
, pp. 188-194
-
-
Prestle, J.1
Janssen, P.M.2
Janssen, A.P.3
-
80
-
-
0035969990
-
Mutations of the cardiac ryanodine receptor (RyR2) gene in familial polymorphic ventricular tachycardia
-
Laitinen PJ, Brown KM, Piippo K, et al: Mutations of the cardiac ryanodine receptor (RyR2) gene in familial polymorphic ventricular tachycardia. Circulation 2001; 103: 485-490.
-
(2001)
Circulation
, vol.103
, pp. 485-490
-
-
Laitinen, P.J.1
Brown, K.M.2
Piippo, K.3
-
81
-
-
0037125396
-
Screening for ryanodine receptor type 2 mutations in families with effort-induced polymorphic ventricular arrhythmias and sudden death: Early diagnosis of asymptomatic carriers
-
Bauce B, Rampazzo A, Basso C, et al: Screening for ryanodine receptor type 2 mutations in families with effort-induced polymorphic ventricular arrhythmias and sudden death: early diagnosis of asymptomatic carriers. J Am Coll Cardiol 2002; 40: 341-349.
-
(2002)
J Am Coll Cardiol
, vol.40
, pp. 341-349
-
-
Bauce, B.1
Rampazzo, A.2
Basso, C.3
-
82
-
-
0036132550
-
Involvement of the cardiac ryanodine receptor/calcium release channel in catecholaminergic polymorphic ventricular tachycardia
-
Marks AR, Priori S, Memmi M, et al: Involvement of the cardiac ryanodine receptor/calcium release channel in catecholaminergic polymorphic ventricular tachycardia. J Cell Physiol 2002; 190: 1-6.
-
(2002)
J Cell Physiol
, vol.190
, pp. 1-6
-
-
Marks, A.R.1
Priori, S.2
Memmi, M.3
-
83
-
-
0035895322
-
Mutations in the cardiac ryanodine receptor gene (hRyR2) underlie catecholaminergic polymorphic ventricular tachycardia
-
Priori SG, Napolitano C, Tiso N, et al: Mutations in the cardiac ryanodine receptor gene (hRyR2) underlie catecholaminergic polymorphic ventricular tachycardia. Circulation 2001; 103: 196-200.
-
(2001)
Circulation
, vol.103
, pp. 196-200
-
-
Priori, S.G.1
Napolitano, C.2
Tiso, N.3
-
84
-
-
0035253502
-
Identification of mutations in the cardiac ryanodine receptor gene in families affected with arrhythmogenic right ventricular cardiomyopathy type 2 (ARVD2)
-
Tiso N, Stephan DA, Nava A, et al: Identification of mutations in the cardiac ryanodine receptor gene in families affected with arrhythmogenic right ventricular cardiomyopathy type 2 (ARVD2). Hum Mol Genet 2001; 10: 189-194.
-
(2001)
Hum Mol Genet
, vol.10
, pp. 189-194
-
-
Tiso, N.1
Stephan, D.A.2
Nava, A.3
-
85
-
-
3242772173
-
Calcium cycling proteins in heart failure, cardiomyopathy and arrhythmias
-
Minamisawa S, Sato Y, Cho MC: Calcium cycling proteins in heart failure, cardiomyopathy and arrhythmias. Exp Mol Med 2004; 36: 193-203.
-
(2004)
Exp Mol Med
, vol.36
, pp. 193-203
-
-
Minamisawa, S.1
Sato, Y.2
Cho, M.C.3
-
86
-
-
0345490780
-
Altered function and regulation of cardiac ryanodine receptors in cardiac disease
-
Wehrens XH, Marks AR: Altered function and regulation of cardiac ryanodine receptors in cardiac disease. Trends Biochem Sci 2003; 28: 671-678.
-
(2003)
Trends Biochem Sci
, vol.28
, pp. 671-678
-
-
Wehrens, X.H.1
Marks, A.R.2
-
87
-
-
0031046227
-
The mechanism of catecholaminergic polymorphic ventricular tachycardia may be triggered activity due to delayed afterdepolarization
-
Nakajima T, Kaneko Y, Taniguchi Y, et al: The mechanism of catecholaminergic polymorphic ventricular tachycardia may be triggered activity due to delayed afterdepolarization. Eur Heart J 1997; 18: 530-531.
-
(1997)
Eur Heart J
, vol.18
, pp. 530-531
-
-
Nakajima, T.1
Kaneko, Y.2
Taniguchi, Y.3
-
88
-
-
0032038691
-
2+ signaling in transgenic mouse cardiac myocytes overexpressing calsequestrin
-
2+ signaling in transgenic mouse cardiac myocytes overexpressing calsequestrin. J Clin Invest 1998; 101: 1385-1393.
-
(1998)
J Clin Invest
, vol.101
, pp. 1385-1393
-
-
Jones, L.R.1
Suzuki, Y.J.2
Wang, W.3
-
89
-
-
0033794867
-
Cardiac-specific overexpression of calsequestrin results in left ventricular hypertrophy, depressed force-frequency relation, and pulsus alternans in vivo
-
Schmidt A, Kadambi V, Ball N, et al: Cardiac-specific overexpression of calsequestrin results in left ventricular hypertrophy, depressed force-frequency relation, and pulsus alternans in vivo. J Mol Cell Cardiol 2000; 32: 1735-1744.
-
(2000)
J Mol Cell Cardiol
, vol.32
, pp. 1735-1744
-
-
Schmidt, A.1
Kadambi, V.2
Ball, N.3
-
90
-
-
0037283739
-
Compensated hypertrophy of cardiac ventricles in aged transgenic FVB/N mice overexpressing calsequestrin
-
Sato Y, Schmidt AG, Kiriazis H, et al: Compensated hypertrophy of cardiac ventricles in aged transgenic FVB/N mice overexpressing calsequestrin. Mol Cell Biochem 2003; 242: 19-25.
-
(2003)
Mol Cell Biochem
, vol.242
, pp. 19-25
-
-
Sato, Y.1
Schmidt, A.G.2
Kiriazis, H.3
-
91
-
-
0032561337
-
Cardiac-specific overexpression of mouse cardiac calsequestrin is associated with depressed cardiovascular function and hypertrophy in transgenic mice
-
Sato Y, Ferguson D, Sako H, et al: Cardiac-specific overexpression of mouse cardiac calsequestrin is associated with depressed cardiovascular function and hypertrophy in transgenic mice. J Biological Chemistry 1998; 273: 28470-28477.
-
(1998)
J Biological Chemistry
, vol.273
, pp. 28470-28477
-
-
Sato, Y.1
Ferguson, D.2
Sako, H.3
-
92
-
-
0033529637
-
Defective beta-adrenergic receptor signaling precedes the development of dilated cardiomyopathy in transgenic mice with calsequestrin overexpression
-
Cho MC, Rapacciuolo A, Koch WJ, et al: Defective beta-adrenergic receptor signaling precedes the development of dilated cardiomyopathy in transgenic mice with calsequestrin overexpression. J Biol Chem 1999; 274: 22251-22256.
-
(1999)
J Biol Chem
, vol.274
, pp. 22251-22256
-
-
Cho, M.C.1
Rapacciuolo, A.2
Koch, W.J.3
-
93
-
-
0141482017
-
Calsequestrin determines the functional size and stability of cardiac intracellular calcium stores: Mechanism for hereditary arrhythmia
-
Terentyev D, Viatchenko-Karpinski S, Gyorke I, et al: Calsequestrin determines the functional size and stability of cardiac intracellular calcium stores: Mechanism for hereditary arrhythmia. Proc Natl Acad Sci U S A 2003; 100: 11759-11764.
-
(2003)
Proc Natl Acad Sci U S A
, vol.100
, pp. 11759-11764
-
-
Terentyev, D.1
Viatchenko-Karpinski, S.2
Gyorke, I.3
-
94
-
-
12144288503
-
Abnormal calcium signaling and sudden cardiac death associated with mutation of calsequestrin
-
Viatchenko-Karpinski S, Terentyev D, Gyorke I, et al: Abnormal calcium signaling and sudden cardiac death associated with mutation of calsequestrin. Circ Res 2004; 94: 471-477.
-
(2004)
Circ Res
, vol.94
, pp. 471-477
-
-
Viatchenko-Karpinski, S.1
Terentyev, D.2
Gyorke, I.3
-
95
-
-
0029810545
-
Unaltered ryanodine receptor protein levels in ischemic cardiomyopathy
-
Schillinger W, Meyer M, Kuwajima G, et al: Unaltered ryanodine receptor protein levels in ischemic cardiomyopathy. Mol Cell Biochem 1996, 160-161: 297-302.
-
(1996)
Mol Cell Biochem
-
-
Schillinger, W.1
Meyer, M.2
Kuwajima, G.3
-
96
-
-
0026644822
-
2+ channel) and calsequestrin genes in the myocardium of patients with end-stage heart failure
-
2+ channel) and calsequestrin genes in the myocardium of patients with end-stage heart failure. J Clin Invest 1992; 90: 927-935.
-
(1992)
J Clin Invest
, vol.90
, pp. 927-935
-
-
Takahashi, T.1
Allen, P.D.2
Lacro, R.V.3
-
97
-
-
0027506532
-
Alterations in sarcoplasmic reticulum gene expression in human heart failure. A possible mechanism for alterations in systolic and diastolic properties of the failing myocardium
-
Arai M, Alpert NR, MacLennan DH, et al: Alterations in sarcoplasmic reticulum gene expression in human heart failure. A possible mechanism for alterations in systolic and diastolic properties of the failing myocardium. Circ Res 1993; 72: 463-469.
-
(1993)
Circ Res
, vol.72
, pp. 463-469
-
-
Arai, M.1
Alpert, N.R.2
MacLennan, D.H.3
-
98
-
-
0028100606
-
Ca(2+)-transporting ATPase, phospholamban, and calsequestrin levels in nonfailing and failing human myocardium
-
Movsesian MA, Karimi M, Green K, et al: Ca(2+)-transporting ATPase, phospholamban, and calsequestrin levels in nonfailing and failing human myocardium. Circulation 1994; 90: 653-657.
-
(1994)
Circulation
, vol.90
, pp. 653-657
-
-
Movsesian, M.A.1
Karimi, M.2
Green, K.3
-
99
-
-
3142538602
-
Defective glycosylation of calsequestrin in heart failure
-
Kiarash A, Kelly CE, Phinney BS, et al: Defective glycosylation of calsequestrin in heart failure. Cardiovasc Res 2004; 63: 264-272.
-
(2004)
Cardiovasc Res
, vol.63
, pp. 264-272
-
-
Kiarash, A.1
Kelly, C.E.2
Phinney, B.S.3
-
100
-
-
0037131020
-
Absence of calsequestrin 2 causes severe forms of catecholaminergic polymorphic ventricular tachycardia
-
Postma AV, Denjoy I, Hoorntje TM, et al: Absence of calsequestrin 2 causes severe forms of catecholaminergic polymorphic ventricular tachycardia. Circ Res 2002, 91: e21-26.
-
(2002)
Circ Res
, vol.91
-
-
Postma, A.V.1
Denjoy, I.2
Hoorntje, T.M.3
-
101
-
-
0035205336
-
A missense mutation in a highly conserved region of CASQ2 is associated with autosomal recessive catecholamine-induced polymorphic ventricular tachycardia in Bedouin families from Israel
-
Lahat H, Pras E, Olender T, et al: A missense mutation in a highly conserved region of CASQ2 is associated with autosomal recessive catecholamine-induced polymorphic ventricular tachycardia in Bedouin families from Israel. Am J Hum Genet 2001; 69: 1378-1384.
-
(2001)
Am J Hum Genet
, vol.69
, pp. 1378-1384
-
-
Lahat, H.1
Pras, E.2
Olender, T.3
-
102
-
-
5444269245
-
Calsequestrin mutant D307H exhibits depressed binding to its protein targets and a depressed response to calcium
-
Houle TD, Ram ML, Cala SE: Calsequestrin mutant D307H exhibits depressed binding to its protein targets and a depressed response to calcium. Cardiovasc Res 2004; 64: 227-233.
-
(2004)
Cardiovasc Res
, vol.64
, pp. 227-233
-
-
Houle, T.D.1
Ram, M.L.2
Cala, S.E.3
-
103
-
-
0035830828
-
Cardiac hypertrophy and impaired relaxation in transgenic mice overexpressing triadin 1
-
Kirchhefer U, Neumann J, Baba HA, et al: Cardiac hypertrophy and impaired relaxation in transgenic mice overexpressing triadin 1. J Biol Chem 2001; 276: 4142-4149.
-
(2001)
J Biol Chem
, vol.276
, pp. 4142-4149
-
-
Kirchhefer, U.1
Neumann, J.2
Baba, H.A.3
-
104
-
-
12144289713
-
2+ handling and leads to a blunted contractile response to beta-adrenergic agonists
-
2+ handling and leads to a blunted contractile response to beta-adrenergic agonists. Cardiovasc Res 2004; 62: 122-134.
-
(2004)
Cardiovasc Res
, vol.62
, pp. 122-134
-
-
Kirchhefer, U.1
Jones, L.R.2
Begrow, F.3
-
105
-
-
10744228510
-
Impaired relaxation in transgenic mice overexpressing junctin
-
Kirchhefer U, Neumann J, Bers DM, et al: Impaired relaxation in transgenic mice overexpressing junctin. Cardiovasc Res 2003; 59: 369-379.
-
(2003)
Cardiovasc Res
, vol.59
, pp. 369-379
-
-
Kirchhefer, U.1
Neumann, J.2
Bers, D.M.3
-
106
-
-
7244257742
-
Age-dependent biochemical and contractile properties in atrium of transgenic mice overexpressing junctin
-
Kirchhefer U, Baba HA, Hanske G, et al: Age-dependent biochemical and contractile properties in atrium of transgenic mice overexpressing junctin. Am J Physiol Heart Circ Physiol 2004; 287: H2216-2225.
-
(2004)
Am J Physiol Heart Circ Physiol
, vol.287
-
-
Kirchhefer, U.1
Baba, H.A.2
Hanske, G.3
-
107
-
-
0036674423
-
Cardiac remodeling and atrial fibrillation in transgenic mice overexpressing junctin
-
Hong CS, Cho MC, Kwak YG, et al: Cardiac remodeling and atrial fibrillation in transgenic mice overexpressing junctin. Faseb J 2002; 16: 1310-1312.
-
(2002)
Faseb J
, vol.16
, pp. 1310-1312
-
-
Hong, C.S.1
Cho, M.C.2
Kwak, Y.G.3
-
108
-
-
0032851553
-
Interaction of triadin with histidine-rich Ca(2+)-binding protein at the triadic junction in skeletal muscle fibers
-
Sacchetto R, Turcato F, Damiani E, et al: Interaction of triadin with histidine-rich Ca(2+)-binding protein at the triadic junction in skeletal muscle fibers. J Muscle Res Cell Motil 1999; 20: 403-415.
-
(1999)
J Muscle Res Cell Motil
, vol.20
, pp. 403-415
-
-
Sacchetto, R.1
Turcato, F.2
Damiani, E.3
-
109
-
-
0035930972
-
Ca(2+)-dependent interaction of triadin with histidine-rich Ca(2+)-binding protein carboxyl-terminal region
-
Sacchetto R, Damiani E, Turcato F, et al: Ca(2+)-dependent interaction of triadin with histidine-rich Ca(2+)-binding protein carboxyl-terminal region. Biochem Biophys Res Commun 2001; 289: 1125-1134.
-
(2001)
Biochem Biophys Res Commun
, vol.289
, pp. 1125-1134
-
-
Sacchetto, R.1
Damiani, E.2
Turcato, F.3
-
110
-
-
0025838068
-
Subcellular fractionation to junctional sarcoplasmic reticulum and biochemical characterization of 170 kDa Ca(2+)- and low-density-lipoprotein-binding protein in rabbit skeletal muscle
-
Damiani E, Margreth A: Subcellular fractionation to junctional sarcoplasmic reticulum and biochemical characterization of 170 kDa Ca(2+)- and low-density-lipoprotein-binding protein in rabbit skeletal muscle. Biochem J 1991, 277 (Pt 3): 825-832.
-
(1991)
Biochem J
, vol.277
, Issue.PART 3
, pp. 825-832
-
-
Damiani, E.1
Margreth, A.2
-
111
-
-
0028906112
-
Identification of triadin and of histidine-rich Ca(2+)-binding protein as substrates of 60 kDa calmodulin-dependent protein kinase in junctional terminal cisternae of sarcoplasmic reticulum of rabbit fast muscle
-
Damiani E, Picello E, Saggin L, et al: Identification of triadin and of histidine-rich Ca(2+)-binding protein as substrates of 60 kDa calmodulin-dependent protein kinase in junctional terminal cisternae of sarcoplasmic reticulum of rabbit fast muscle. Biochem Biophys Res Commun 1995; 209: 457-465.
-
(1995)
Biochem Biophys Res Commun
, vol.209
, pp. 457-465
-
-
Damiani, E.1
Picello, E.2
Saggin, L.3
-
113
-
-
0030583215
-
Modulation of the skeletal muscle ryanodine receptor by endogenous phosphorylation of 160/150-kDa proteins of the sarcoplasmic reticulum
-
Orr I, Shoshan-Barmatz V: Modulation of the skeletal muscle ryanodine receptor by endogenous phosphorylation of 160/150-kDa proteins of the sarcoplasmic reticulum. Biochim Biophys Acta 1996; 1283: 80-88.
-
(1996)
Biochim Biophys Acta
, vol.1283
, pp. 80-88
-
-
Orr, I.1
Shoshan-Barmatz, V.2
-
114
-
-
0030583220
-
The identification of the phosphorylated 150/160-kDa proteins of sarcoplasmic reticulum, their kinase and their association with the ryanodine receptor
-
Shoshan-Barmatz V, Orr I, Weil S, et al: The identification of the phosphorylated 150/160-kDa proteins of sarcoplasmic reticulum, their kinase and their association with the ryanodine receptor. Biochim Biophys Acta 1996; 1283: 89-100.
-
(1996)
Biochim Biophys Acta
, vol.1283
, pp. 89-100
-
-
Shoshan-Barmatz, V.1
Orr, I.2
Weil, S.3
-
115
-
-
0033527403
-
2+ binding protein) resides in the lumen of sarcoplasmic reticulum as a multimer
-
2+ binding protein) resides in the lumen of sarcoplasmic reticulum as a multimer. Biochem Biophys Res Commun 1999; 263: 667-671.
-
(1999)
Biochem Biophys Res Commun
, vol.263
, pp. 667-671
-
-
Suk, J.Y.1
Kim, Y.S.2
Park, W.J.3
-
116
-
-
0035955601
-
Interaction of HRC (histidine-rich Ca(2+)-binding protein) and triadin in the lumen of sarcoplasmic reticulum
-
Lee HG, Kang H, Kim DH, et al: Interaction of HRC (histidine-rich Ca(2+)-binding protein) and triadin in the lumen of sarcoplasmic reticulum. J Biol Chem 2001; 276: 39533-39538.
-
(2001)
J Biol Chem
, vol.276
, pp. 39533-39538
-
-
Lee, H.G.1
Kang, H.2
Kim, D.H.3
-
117
-
-
0024419447
-
2+-binding protein of sarcoplasmic reticulum that contains highly conserved repeated elements
-
2+-binding protein of sarcoplasmic reticulum that contains highly conserved repeated elements. J Biol Chem 1989; 264: 18083-18090.
-
(1989)
J Biol Chem
, vol.264
, pp. 18083-18090
-
-
Hofmann, S.L.1
Goldstein, J.L.2
Orth, K.3
-
118
-
-
0037207513
-
Increased Ca(2+) storage capacity in the sarcoplasmic reticulum by overexpression of HRC (histidine-rich Ca(2+) binding protein)
-
Kim E, Shin DW, Hong CS, et al: Increased Ca(2+) storage capacity in the sarcoplasmic reticulum by overexpression of HRC (histidine-rich Ca(2+) binding protein). Biochem Biophys Res Commun 2003; 300: 192-196.
-
(2003)
Biochem Biophys Res Commun
, vol.300
, pp. 192-196
-
-
Kim, E.1
Shin, D.W.2
Hong, C.S.3
-
119
-
-
4744350102
-
Regulation of myocardial function by histidine-rich, calcium-binding protein
-
Fan GC, Gregory KN, Zhao W, et al: Regulation of myocardial function by histidine-rich, calcium-binding protein. Am J Physiol Heart Circ Physiol 2004, 287: H1705-1711.
-
(2004)
Am J Physiol Heart Circ Physiol
, vol.287
-
-
Fan, G.C.1
Gregory, K.N.2
Zhao, W.3
-
120
-
-
33646093733
-
Histidine-rich Ca binding protein: A regulator of sarcoplasmic reticulum calcium sequestration and cardiac function
-
Gregory KN, Ginsburg KS, Bodi I, et al: Histidine-rich Ca binding protein: a regulator of sarcoplasmic reticulum calcium sequestration and cardiac function. J Mol Cell Cardiol 2006; 40: 653-665.
-
(2006)
J Mol Cell Cardiol
, vol.40
, pp. 653-665
-
-
Gregory, K.N.1
Ginsburg, K.S.2
Bodi, I.3
-
122
-
-
0026080381
-
cDNA and genomic cloning of HRC, a human sarcoplasmic reticulum protein, and localization of the gene to human chromosome 19 and mouse chromosome 7
-
Hofmann SL, Topham M, Hsieh CL, et al: cDNA and genomic cloning of HRC, a human sarcoplasmic reticulum protein, and localization of the gene to human chromosome 19 and mouse chromosome 7. Genomics 1991; 9: 656-669.
-
(1991)
Genomics
, vol.9
, pp. 656-669
-
-
Hofmann, S.L.1
Topham, M.2
Hsieh, C.L.3
-
123
-
-
0029112853
-
An isolated cardiac conduction disease maps to chromosome 19q
-
de Meeus A, Stephan E, Debrus S, et al: An isolated cardiac conduction disease maps to chromosome 19q. Circ Res 1995; 77: 735-740.
-
(1995)
Circ Res
, vol.77
, pp. 735-740
-
-
de Meeus, A.1
Stephan, E.2
Debrus, S.3
|